| HST Global Announces Launch of FocusUP Website |
HAMPTON, Va.--(BUSINESS WIRE)-- HST Global, Inc. (OTCBB: HSTC) today announced the official launch of the FocusUP(R) FocusUP(R) is the cognitive function product endorsed and recommended by Dr. Kyl Smith under a Joint Venture with Dalham, LLC (an affiliate company of The Health Network, Inc. ).
Ron Howell, CEO/President stated, "We are pleased to announce the launch of our new FocusUP(R) website. With the introduction of the new website, we will have the ability to educate the public on the benefits of FocusUP (R), Dr. Kyl Smith's cognitive function product.
About HST Global, Inc.
HST Global, Inc. is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the immunotherapy and alternative treatment of late stage cancer. In addition, the company intends to acquire innovative products for the treatment of late stage cancer. In this regard, the company primarily focuses on immunotherapy and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer.
| HST GLOBAL, INC Stock Symbol :: HSTC |
|
| ST GLOBAL, INC (HSTC) HST Global, Inc. is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the immunotherapy and alternative treatment of late stage cancer. | ||||||||||||
HST Global, Inc. 150 Research Drive Hampton, VA 23666 Phone: 757-766-6100 Fax: http://www.hstc-alternativecancercure.com/ |
· HealthSouth Corporation (HealthSouth) is a provider of inpatient rehabilitative healthcare services. The Company operates 93 inpatient rehabilitation hospitals, six freestanding long-term acute care hospitals (LTCHs), 49 outpatient rehabilitation satellites (operated by its hospitals), and 25 licensed, hospital-based home health agencies. LTCHs provide medical treatment to patients with chronic diseases and/or complex medical conditions. NYSE:HLS Recent Price: $12.76
· Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. The Company manages and/or owns outright or in partnerships with physicians, nine surgical hospitals and surgery and radiation oncology centers located in six states and Puerto Rico. NYSE:UHS Recent Price: $54.92 |
 | HST Global Signs Agreement to Acquire Central American Immunotherapy Company HST Global, Inc. has entered into a Letter of Intent to acquire the assets of a Central American Immunotherapy Company. The acquisition will include a family of immunotherapy products that have been approved for the treatment of patients as an alternative to or as an adjunct therapy before, during and after traditional cancer treatments. HST anticipates completing the pending acquisition of the company at the conclusion of the due diligence period. This pending acquisition is a part of the evolution of HST’s development of a global presence in the emerging immunotherapy treatment of cancer. | HST Global Enters into Letter of Intent to Acquire Treatment Facility
HST Global, Inc. recently announced it is reaching across the globe to insure that immunotherapy and alternative treatments and solutions are available to all communities. Alternative therapies are achieving extraordinary degrees of successHST anticipates completing the acquisition of the center in the next ninety days. The company intends to open three to five centers worldwide during 2009. This acquisition will allow the company to provide alternative health care options for those who are suffering from late stage cancer |
| Company Overview |
HST Global, Inc. (OTCBB: HSTC)
HST Global, Inc. is an integrated biotechnology and wellness company developing a network of "FIT" Wellness Centers worldwide. We specialize in innovative technologies for the treatment of cancer and other life threatening illnesses.
The growing acceptance of alternative cancer treatments worldwide has placed HST Global in perfect position to launch its own brand of Cancer Treatment Centers. While the company continues to look for in-licensing pre-clinical drug candidates, this strategy will enable the company to address the challenges individuals face in the treatment of cancer in the later stages.
Cancer is an epidemic that is worldwide and one that does not discriminate. HST Global, Inc. has been involved with pre-clinical and proven drug candidates that have shown high efficacy in the treatment of various cancers. The success and high efficacy achieved in these treatments has given the company a position of visibility that has attracted a number of International partners that want to move forward and open Centers worldwide.
There is a growing population of individuals experiencing the lack of available alternatives in treating late stage cancer. HST Global, Inc. has been working with a number of highly visible Physicians that are developing and have developed successful protocols that are meeting with success in the treatment of this population. As such, the company will begin opening a privately branded chain of Cancer Treatment Centers strategically positioned around the world. The distribution channel established through these Cancer Treatment Centers will serve as a platform for implementing existing technologies and serve to identify appropriate communities for treatment with new and emerging drug candidates as they become available.
Due to the unfortunate nature of cancer, the Company is not as affected by current and/or future economic conditions. The Company’s intention is to provide World-Class treatment of this and other life threatening diseases.
In February, the Company announced a project that has been initiated with EBITDA Capital, LLC for both shareholder participation and health and wellness center operations within Saudi Arabia.
HST Global, Inc has given authority to EBITDA Capital, LLC to begin working with EBITDA’s contacts and clients within the Kingdom of Saudi Arabia. Key clientele within the Royal Family have expressed an interest in becoming shareholders in HSTC. In addition, they have shown an interest in opening and operating a health and wellness clinic based within the Gulf Cooperation Council Countries (GCC). The health and wellness clinics would include both for-profit and non-profit treatment facilities in support of HSTC’s late stage cancer applications. HSTC would be responsible for the training, maintenance and management development in these clinics.
Mr. Chet Noblett, Managing General Partner of EBITDA, is currently assisting HSTC with the initial negotiations and is leveraging his long term relationships with these parties. Mr. Noblett says, "We have been cautiously opening the window of opportunity for HSTC with our associates in Saudi Arabia. Health care is a top priority throughout the GCC and HSTC offers the opportunity to energize the effort by establishing these clinics. We are very pleased to have the level of interest and acceptance that has been expressed at this time."
Ron Howell, President and CEO of HST Global, Inc., stated, "The commencement of this initiative within the GCC Countries characterizes the essence of what HSTC is developing. The combined capital and strategic operational partnership will bring an affordable, yet cost effective treatment for late stage cancer to the GCC. HSTC is reaching across the Globe with its brand of alternative health and wellness centers."
Recently EBITDA Capital initiated negotiations with known contacts within the Native American community for the purpose of placing health and wellness centers on tribal reservations. They are currently working with several Native American nations and they have been very receptive to the HST Global proposals. Native Americans have always believed in the concept of being healers.
HSTC is reaching across the globe to insure that its treatments and solutions are available to all communities. The Native American communities are positioned in locations that make these clinics accessible to both Native and Non-Native American people.
LEADERSHIP
Ronald R. Howell, President
| News |
- HST Global Announces Launch of FocusUP Website
August 19, 2009 - HST Global, Inc. to Announce Second Quarter Results
August 10, 2009 - HST Global to Offer Free Samples of FocusUP
August 7, 2009 - New featured Report on OTCReporter.com HSTC
August 6, 2009
No comments:
Post a Comment